Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
4.91M
-
Shares change
-
+94.8K
-
Total reported value, excl. options
-
$7.66M
-
Value change
-
+$48.4K
-
Put/Call ratio
-
2.65
-
Number of buys
-
21
-
Number of sells
-
-20
-
Price
-
$1.56
Significant Holders of Fortress Biotech, Inc. - COM NEW (FBIO) as of Q1 2025
59 filings reported holding FBIO - Fortress Biotech, Inc. - COM NEW as of Q1 2025.
Fortress Biotech, Inc. - COM NEW (FBIO) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.91M shares
.
Largest 10 shareholders include Cambridge Investment Research Advisors, Inc. (1M shares), VANGUARD GROUP INC (753K shares), PVG ASSET MANAGEMENT CORP (472K shares), Nantahala Capital Management, LLC (326K shares), Kestra Advisory Services, LLC (292K shares), ENVESTNET ASSET MANAGEMENT INC (268K shares), GEODE CAPITAL MANAGEMENT, LLC (238K shares), SHIKIAR ASSET MANAGEMENT INC (236K shares), BlackRock, Inc. (116K shares), and HB Wealth Management, LLC (113K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.